Roche

Bio Roundup: EQRx's Ambitions, Nektar No Vote, New Frazier Fund & More

Bio Roundup: EQRx's Ambitions, Nektar No Vote, New Frazier Fund & More

2 days ago   |   Xconomy

Perhaps the most talked-about news at the JP Morgan Healthcare Conference this week was a new startup that launched with $200 million and an ambitious claim its first drug...
Read more ...

Illumina Announces New Sequencing System, Partnership with Roche and Software Suite to Accelerate Adoption of Genomics

6 days ago   |   San Diego Biotechnology

SAN DIEGO--Illumina, Inc. further demonstrated its commitment to making genomics more accessible for the potential benefit of patients today with a series of technology and...
Read more ...

Roche Pays $40M to Use Amunix Pharma's Half-Life Extension Tech

Roche Pays $40M to Use Amunix Pharma's Half-Life Extension Tech

6 days ago   |   Xconomy

Roche will pay Amunix Pharmaceuticals $40 million up front to use the company's proprietary technology to discover and develop new drugs outside of the oncology space. The...
Read more ...

Eli Lilly Gets Skin in the Eczema Game With $1.1B Deal for Dermira

Eli Lilly Gets Skin in the Eczema Game With $1.1B Deal for Dermira

9 days ago   |   Xconomy   |   2 articles

Eli Lilly has agreed to acquire dermatology drug developer Dermira and its late-stage atopic dermatitis drug for $1.1 billion. Lilly will pay $18.75 per share, a 2.2 percent...
Read more ...

After Antitrust Challenges, Illumina and PacBio Throw in Towel on Merger

After Antitrust Challenges, Illumina and PacBio Throw in Towel on Merger

16 days ago   |   Xconomy   |   2 articles

DNA sequencing machine maker Illumina will have to find another way to “read” long pieces of genetic material as well as short stretches, the genomic giant's bailiwick. Its...
Read more ...

Wave tanks again as Huntington's clinical trial data underwhelm

17 days ago   |   Fierce Biotech

Data from a phase 1b/2a trial have raised doubts about whether Wave Life Sciences' Huntington's disease drug can compete with Roche and Ionis' rival candidate. The results...
Read more ...

An immuno-oncology triplet from Roche shows promise in mouse models of several tumors

17 days ago   |   Fierce Biotech

Targeting CD40, a receptor on the surface of immune cells, stimulates cancer-killing T cells. University of Basel researchers combined an investigational CD40-targeted antibody...
Read more ...

Sensyne Health pairs with Roche for AI trial work

21 days ago   |   Fierce Biotech

Oxford, U.K.-based clinical trial artificial intelligence tech company Sensyne Health has signed a new research project deal with Swiss major Roche.
Read more ...

Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal

Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal

26 days ago   |   Xconomy

Swiss biopharma Roche is betting more than $1 billion that Sarepta Therapeutics, which recently won FDA approval for its second RNA medicine for Duchenne muscular dystrophy...
Read more ...

Roche to pay Sarepta $1B upfront for DMD gene therapy rights

27 days ago   |   Fierce Biotech

Roche is paying more than $1 billion upfront for the ex-U.S. rights to Sarepta's Duchenne muscular dystrophy gene therapy SRP-9001. The deal comes days after Roche advanced its...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Interfacial molecular interactions of cellobiohydrolase Cel7A and its...

Molecular-scale mechanisms of the enzymatic breakdown of cellulosic biomass into fermentable sugars are still poorly understood, with a need for independent measurements of... Read more ...

Brassinosteroid overproduction improves lignocellulose quantity and quality...

As a leading biomass feedstock, poplar plants provide enormous lignocellulose resource convertible for biofuels and bio-chemicals. However, lignocellulose recalcitrance... Read more ...

US biofuel production and policy: implications for land use changes in...

It has been argued that the US biofuel policy is responsible for the land use changes in Malaysia and Indonesia. In this paper, following a short literature review that... Read more ...

Programmable nests for cells

Using DNA, smallest silica particles, and carbon nanotubes, researchers developed novel programmable materials. These nanocomposites can be tailored to various applications and... Read more ...

AveXis Inc.: Research Associate III

AveXis Inc.: OverviewReady to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological gene San Diego... Read more ...

Mirati Therapeutics: Student Assistant

Mirati Therapeutics: Mirati Therapeutics is a targeted oncology company developing an advanced pipeline of breakthrough medicines for precisely defined patient populations San... Read more ...

Inhibition of lignification of Zizania latifolia with radio frequency...

Zizania latifolia is easily lignified after harvesting, leading to the degradation of food quality and commercial value. Thus, this study evaluated the effect of radio... Read more ...

Performance difference of graph-based and alignment-based hybrid error...

The error-prone third-generation sequencing long reads can be corrected by the high-quality second-generation sequencing short reads, which is referred to as hybrid error... Read more ...

CHROMATIX: computing the functional landscape of many-body chromatin...

Chromatin interactions are important for gene regulation and cellular specialization. Emerging evidence suggests many-body spatial interactions play important roles in... Read more ...

Bachem: Validation Engineer II, QA

Bachem: Your Responsibilities The Validation Engineer II fulfills a critical role in GMP operations. This individual must plan and execute validation studies, Vista, CA, US ... Read more ...